Baijin Life Science Holdings Limited (HKG:1466)

Hong Kong · Delayed Price · Currency is HKD

0.9300

-0.0200 (-2.11%)

Jul 31, 2026, 3:59 PM HKT

HKG:1466 Financials Overview

Financials in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	89.3	89.3	135.56	53.68	86.88	62.65
Revenue Growth	-25.46%	-34.12%	152.54%	-38.22%	38.68%	44.60%
Gross Profit	6.67	6.67	41.99	18.1	7.83	10.99
Operating Income	-30.88	-30.88	14.05	-9.58	-2.67	-0.23
Net Income	-37.87	-37.87	-0.32	-7.45	8.68	-15.46
Earnings Per Share	-0.06	-0.06	-0.00	-0.01	0.01	-0.04
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Jewellery Business	63.57	63.57	115.19	50.35	85.23	59.94
Skincare Business	25.73	25.73	20.37	3.33	-	-
Total	89.3	89.3	135.56	53.68	86.88	62.65

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	44.04	44.04	48.57	38.59	41.85	24.17
Total Debt	28.41	28.41	99.93	51.19	2.76	31.84
Net Cash (Debt)	15.63	15.63	-51.36	-12.6	39.09	-7.67
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.02	0.02	-0.07	-0.02	0.06	-0.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	-	-30.53	-6.46	-21.52	1.11
Capital Expenditures	-	-	-2.45	-0.18	-0.03	-0.05
Free Cash Flow	-	-	-32.97	-6.64	-21.55	1.06
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	7.46%	7.46%	30.97%	33.72%	9.01%	17.55%
Operating Margin	-34.57%	-34.57%	10.36%	-17.85%	-3.08%	-0.36%
Pretax Margin	-48.27%	-48.27%	-1.01%	-15.89%	9.99%	-24.68%
Profit Margin	-42.40%	-42.40%	-0.23%	-13.88%	9.99%	-24.68%
FCF Margin	-	-	-24.32%	-12.36%	-24.80%	1.70%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	-	-	-	-	52.32	-
P/FCF Ratio	-	-	-	-	-	36.69
PS Ratio	9.40	6.16	3.60	8.23	5.22	0.62